glp 1 receptor agonists GLP-1 show promise in treating substance use disorders The Impact of GLP-1 Receptor

Retatrutide has already demonstrated impressive weight loss and encouraging improvements across multiple metabolic markers, making it one of the most closely watched investigational therapies in endocrinology

Zepbound (tirzepatide) is an injectable prescription medicine approved for the treatment of obesity

Gorgojo-Martnez JJ, Mezquita-Raya P, Carretero-Gmez J, Castro A, Cebrin-Cuenca A, de Torres-Snchez A, Garca-de-Lucas MD, Nez J, Obaya JC, Soler MJ, Grriz JL, Rubio-Herrera M

Additionally, GLP-1RAs may influence other neurological functions, inter alia in pain modulation

GLP-1 RAs have been shown to induce phosphorylation and inactivation of NHE3 (Muskiet et al., 2017)